Therapeutic intervention in glomerulonephritis by oligonucleotides.
Kashihara
N
N
Department of Medicine III, Okayama University Medical School, Japan.
Maeshima
Y
Y
Makino
H
H
D000818:Animals; D002453:Cell Cycle / Q000235:genetics; D015316:Genetic Therapy / Q000379:methods*; D005920:Glomerular Mesangium / Q000378:metabolism; D005921:Glomerulonephritis / Q000628:therapy*; D006801:Humans; D009687:Nuclear Proteins / Q000235:genetics; D016376:Oligonucleotides, Antisense / Q000627:therapeutic use*; D011518:Proto-Oncogene Proteins / Q000096:biosynthesis; D020598:Proto-Oncogene Proteins c-myb; D016271:Proto-Oncogene Proteins c-myc / Q000096:biosynthesis; D011519:Proto-Oncogenes; D016337:RNA, Catalytic / Q000235:genetics; D015534:Trans-Activators / Q000096:biosynthesis
D009687:Nuclear Proteins; D016376:Oligonucleotides, Antisense; D011518:Proto-Oncogene Proteins; D020598:Proto-Oncogene Proteins c-myb; D016271:Proto-Oncogene Proteins c-myc; D016337:RNA, Catalytic; D015534:Trans-Activators